The global bioprocess container market is anticipated to grow at a CAGR of 14.0% during the forecast period (2022-2028). The term "single-use technology" involves a broad range of disposable, modular and flexible technologies that can be scaled not only to a range of volumes, however, also for a wide variety of applications, including upscale bioprocessing, filling and the entire logistics process. The growing integration of single-use technology in the bioproduction market creates a positive, long-term impact on production efficiencies and flexibility in manufacturing. As the biopharmaceutical industry matures, the trend toward increased flexibility and productivity, faster time to market and greater profitability are driving the replacement of traditional stainless steel equipment with single-use technology (SUT). For instance, in April 2022, Thermo Fisher, a bioprocess container manufacturing company announced to expand its manufacturing site in Ogden, Utah for developing vaccines and therapies. In February 2022, the company invested $40 million to expand its Millersburg, Pennsylvania plant to support the production of SUT for vaccines and therapeutics.
Browse the full report description of “Bioprocess Container Market Size, Share & Trends Analysis Report, By Type (2D Bioprocess Containers, 3D Bioprocess Containers, and Other Containers and Accessories), By Type (Upstream Processes, Downstream, Processes, and Process Development), By End-User (Pharmaceutical & Biopharmaceutical Companies, CROs & CMOs, and Academic & Research Institutes), Forecast Period (2022-2028)” at https://www.omrglobal.com/industry-reports/bioprocess-container-market
The use of SUT in the biopharmaceutical industry significantly impacts the manufacturing process efficiency, it eliminates the need for steam, chemicals, and water to clean and sterilize stainless vessels, which provides a direct reduction in capital cost and mitigation of environmental impact. Single-use platforms also increase equipment and process flexibility significantly, making it possible to switch campaigns from one product to another in minimal time, while eliminating cleaning and associated validation steps. In addition, it significantly reduces process liquid waste, labor costs, and on-site quality and validation requirements. More and more companies are adopting single-use technologies in the manufacturing process. Also, vendor research and development has led to more reliable products, reducing concerns about bio-container leaks or maintaining material sterility. Manufacturers who have not adopted single-use are now seeing early adopters benefitting from the quick product turnarounds, decreased development times, and simplified operations and equipment.
Market Coverage
• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
o By Type
o By Application
o By End-User
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- Danaher Corp., Thermo Fisher Scientific, Inc., Lonza Group AG, Merck KGaA, and Sartorius AG.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Bioprocess Container Market Report by Segment
By Type
By Application
By End-User
Global Bioprocess Container Market Report by Region
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/bioprocess-container-market